Kancelaria Medius (WAR:KME) Other Stockholders Equity: zł25.29 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:KME Kancelaria Medius SA WAR:KME
31 GF Score
Price zł0.24
GF Value zł0.19
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Kancelaria Medius Other Stockholders Equity?

Kancelaria Medius WAR:KME 31 Other Stockholders Equity is zł25.29 Mil as of Mar. 2026. GuruFocus rates WAR:KME with a GF Score™ of 31/100 and a GF Value™ of zł0.19 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Kancelaria Medius's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł25.29 Mil.

Kancelaria Medius's quarterly Other Stockholders Equity declined from Sep. 2025 (zł76.54 Mil) to Dec. 2025 (zł76.35 Mil) and declined from Dec. 2025 (zł76.35 Mil) to Mar. 2026 (zł25.29 Mil).

Kancelaria Medius's annual Other Stockholders Equity declined from Dec. 2023 (zł25.61 Mil) to Dec. 2024 (zł25.41 Mil) but then increased from Dec. 2024 (zł25.41 Mil) to Dec. 2025 (zł76.35 Mil).

Kancelaria Medius Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kancelaria Medius's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kancelaria Medius Other Stockholders Equity Chart

Kancelaria Medius Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.39 27.11 25.61 25.41 76.35

Kancelaria Medius Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.54 25.66 76.54 76.35 25.29
WAR:KME
31GF Score
Kancelaria Medius SA WAR:KME
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kancelaria Medius Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł25.29 Mil mean?
Kancelaria Medius (WAR:KME) has a Other Stockholders Equity of zł25.29 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kancelaria Medius and its competitors.
Is Kancelaria Medius' Other Stockholders Equity too high?
Kancelaria Medius' current Other Stockholders Equity is zł25.29 Mil. Overall, Kancelaria Medius has a GF Score™ of 31/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kancelaria Medius' Other Stockholders Equity compare to CTAS and CPRT?
Kancelaria Medius' Other Stockholders Equity of zł25.29 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Business Services company?
A good Other Stockholders Equity depends on the Business Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kancelaria Medius and its competitors. Kancelaria Medius's current Other Stockholders Equity is zł25.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kancelaria Medius stock overvalued right now?
Based on GuruFocus' analysis, Kancelaria Medius (WAR:KME) is currently considered Modestly Overvalued. The stock's GF Value™ is zł0.19, compared to a current price of zł0.24 — trading 28.4% above its estimated fair value. The current Other Stockholders Equity is zł25.29 Mil. Kancelaria Medius' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Kancelaria Medius (WAR:KME), the current Other Stockholders Equity is zł25.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kancelaria Medius (WAR:KME) Overvalued in 2026?

Based on GuruFocus' analysis, Kancelaria Medius stock appears to be overvalued. The current stock price of zł0.24 is trading 28.4% above its estimated GF Value™ of zł0.19. GuruFocus considers Kancelaria Medius to be Modestly Overvalued.

Key valuation signals for WAR:KME:

  • Other Stockholders Equity: zł25.29 Mil
  • GF Value™: zł0.19 vs. price of zł0.24 (28.4% above fair value)
  • GF Score™: 31/100 with 4 warning signs

No single metric tells the full story. See the WAR:KME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kancelaria Medius Business Description

Address ul. Babinski 69, Krakow, POL, 30-126
Kancelaria Medius SA is a Poland based company involved in providing debt management and receivables management services. The various services offered by the company include Purchase of debt portfolios, Debt service, Handling of mortgage-secured claims and Law Firm services.
31GF Score

Get the complete analysis for WAR:KME

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.24
Price
zł0.19
GF Value